Gemcitabine

규격

95058-81-4CAS 번호

619-100-6EC 번호

4-amino-1-[(2R,4R,5R)-3,3-difluoro-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]pyrimidin-2-oneIUPAC 명칭

C9H11F2N3O4화학식

263.2 g/mol분자량

gemcitabine; 95058-81-4; 2'-Deoxy-2',2'-difluorocytidine; 2',2'-Difluorodeoxycytidine; dFdC; Gemcitabina; Gemcitabinum; DFdCyd; LY-188011; LY188011; 4-amino-1-[(2R,4R,5R)-3,3-difluoro-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-1,2-dihydropyrimidin-2-one; B76N6SBZ8R; 2',2'-difluoro-2'-deoxycytidine; 4-Amino-1-[(2R,4R,5R)-3,3-difluoro-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]pyrimidin-2-one; NSC-613327; DTXSID3040487; 2'deoxy-2',2'-difluorocytidine; CHEBI:175901; 4-amino-1-((2R,4R,5R)-3,3-difluoro-4-hydroxy-5-(hydroxymethyl)-tetrahydrofuran-2-yl)pyrimidin-2(1H)-one; gemicitabine; 4-amino-1-((2R,4R,5R)-3,3-difluoro-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl)-1,2-dihydropyrimidin-2-one; 4-amino-1-((2R,4R,5R)-3,3-difluoro-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl)pyrimidin-2-one; RefChem:922148; Hydrochloride, Gemcitabine; 2'-deoxy-2'-difluorocytidine; 2' Deoxy 2' Difluorocytidine; DTXCID1020487; L01BC05; 1-(2-oxo-4-amino-1,2-dihydropyrimidin-1-yl)-2-deoxy-2,2-difluororibose; 188011, LY; 2' Deoxy 2',2'' Difluorocytidine 5' O Monophosphate; 619-100-6; 2',2'-DFDC; Difluorodeoxycytidine; Cytidine, 2'-deoxy-2',2'-difluoro-; Gemcitabine free base; MFCD00869720; C9H11F2N3O4; 103882-84-4; 4-amino-1-((2R,4R,5R)-3,3-difluoro-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)pyrimidin-2(1H)-one; Gamcitabine; LY 188011; Folfugem; Gemcel; Zefei; GemLip; Gemcitabinum [INN-Latin]; Gemcitabina [INN-Spanish]; 4-amino-1-[(2R,4R,5R)-3,3-difluoro-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]pyrimidin-2-one; Gemzar (hydrochloride); 95058-81-4 (free base); SR-05000001491; Gemcitabine (USAN/INN); UNII-B76N6SBZ8R; Gecitabine base; 2',2'-DiF-dC; Gemcitabine [USAN:INN:BAN]; CCRIS 8984; Gemcitabine base; HSDB 7567; 2vpp; gemcitabine (Gemzar); NSC 613327; Gemcitabine (Standard); 4pd5; GEMCITABINE [MI]; GEMCITABINE [INN]; 2'-Deoxy-.beta.-D-2',2'-difluorocytidine; GEMCITABINE [HSDB]; GEMCITABINE [USAN]; CHEMBL888; GEMCITABINE [VANDF]; SCHEMBL4295; GEMCITABINE [WHO-DD]; GTPL4793; orb1310791; orb3141250; SCHEMBL16372183; 2-Deoxy-2',2'-difluorocytidine; BDBM429521; GLXC-04598; HMS2089P10; HMS3715N07; med.21724, Compound Gemcitabine; BDBM50247964; DL-215; EBC-11028; HY-17026R; s1714; AKOS015920303; Cytidine, 2'-deoxy-2',2'-difluoro-2'-Deoxy-.beta.-D-2',2'-difluorocytidine; CCG-221183; CS-0643; DB00441; GS-3582; ND04237; 4-Amino-1-[3,3-difluoro-4-hydroxy-5-(hydroxymethyl) tetrahydrofuran-2-yl]-1H-pyrimidin-2-one; NCGC00168784-02; NCGC00168784-08; NCGC00168784-11; NCGC00168784-12; 2'-Deoxy-2',2'-difluor o-D-cytidine; BP-58640; HY-17026; SY097030; G0544; NS00000342; SW199649-2; C07650; D02368; EN300-267822; AB01274777-01; AB01274777-02; AB01274777_05; AB01274777_06; 2`-Deoxy-2`,2`-difluorocytidine; (Gemcitabine); F317792; Q414143; W-60402; SR-05000001491-1; SR-05000001491-2; BRD-K15108141-001-04-1; BRD-K15108141-001-06-6; BRD-K15108141-001-08-2; Z1741982024; 4-AMINO-1-[(2R,4R,5R)-3,3-DIFLUORO-4-HYDROXY-5-(HYDROXYMETHYL)TETRAHYDRO-2-FURANYL]-2(1H)-PYRIMIDINONE동의어